EPCAM and colorectal cancer: Based on the flow cytometry data regarding EpCAM expression across colorectal cancer cell lines, and considering the practical challenge posed by COLO205s semi-adherent properties, HT-115 and HT-29 were chosen for screening EpCAM overexpression, while HRT-18 and T84 were selected for EpCAM knockout/downregulation studies.